Brief: Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
18/07/2023 21:30
July 18 (Reuters) - Harrow Health Inc HROW.O :
* HARROW PROVIDES SELECT PRELIMINARY SECOND QUARTER 2023
FINANCIAL
GUIDANCE
* HARROW HEALTH INC - SEES Q2 2023 REVENUES IN EXCESS OF
$31.0
MILLION COMPARED WITH PRIOR-YEAR Q2 REVENUES OF $23.3 MILLION
* HARROW HEALTH INC - PRELIMINARY Q2 ADJUSTED EBITDA IN
EXCESS OF
$9.3 MILLION
Source text for Eikon: ID:nBw81RJ3Wa
Further company coverage: HROW.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates